Epitope landscape in breast and colorectal cancer

Neil H. Segal, D. Williams Parsons, Karl S. Peggs, Victor Velculescu, Ken W. Kinzler, Bert Vogelstein, James P. Allison

Research output: Contribution to journalArticlepeer-review

Abstract

The finding that individual cancers contain many mutant genes not present in normal tissues has prompted considerable interest in the cancer epitope landscape. To further understand such effects, we applied in silico-based epitope prediction algorithms and high throughput post hoc analysis to identify candidate tumor antigens. Analysis of 1,152 peptides containing missense mutations previously identified in breast and colorectal cancer revealed that individual cancers accumulate on average ∼10 and ∼7 novel and unique HLA-A*0201 epitopes, respectively, including genes implicated in the neoplastic process. These data suggest that, with appropriate manipulation of the immune system, tumor cell destruction in situ may provide a polyvalent tumor vaccine without a requirement for knowledge of the targeted antigens.

Original languageEnglish (US)
Pages (from-to)889-892
Number of pages4
JournalCancer Research
Volume68
Issue number3
DOIs
StatePublished - Feb 1 2008

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Epitope landscape in breast and colorectal cancer'. Together they form a unique fingerprint.

Cite this